SCHEMBL26243792

SCHEMBL26243792

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc4c5cc(-c6cccc(-c7cccc8ccccc78)c6)ccc5oc4c4ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
HSD17B10 Q99714 4/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
ATM Q13315 2/20 0.41
TP53 P04637 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
ALOX5 P09917 1/20 0.39
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26243868 0.96 ALDH1A1 (0.42) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL24585707 0.95 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL26243811 0.95 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL26244156 0.94 ALDH1A1 (0.42) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL26243873 0.93 PIM1 (0.39) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL26243816 0.92 MAPK1 (0.42) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL25679310 0.92 ALDH1A1 (0.42) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL17539820 0.91 ALOX5 (0.41) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL26243748 0.91 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL24586810 0.91 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 US disclosed
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME ORC3, CRY1, SUN2 ALDH1A1 458/4885HPGD 728/4885HSD17B10 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.